References
- Locasciulli A, Vossen J, Bacigalupo A, Hows J, Van Lint M T, Gluckman E, et al. Allogeneic bone marrow transplantation (BMT) for acquired severe aplastic anemia in children. Bone Marrow Transplant 1989; (4 Suppl) 4: 123–125
- Marmont A M, Bacigalupo A. Aplastic anemia, pathogenesis and treatment. Haematologica 1988; 73: 133–141
- Boerwinkle E, Xiong W J, Fourest E, Chan L. Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3’ hypervariable region. Proc Natl Acad Sci USA 1989; 86: 212–216
- Tanaka J, Kasai M, Imamura M, Higa T, Kobayashi S, Hashino S, et al. Evaluation of mixed chimerism by two-step polymerase chain reaction amplification of hypervariable region MCT118 after allogeneic bone marrow transplantation. Ann Hematol 1994; 68: 189–193
- Hermine O, Lefrere F, Bronowicki J P, Mariette X, Jondeau K, Eclache-Saudreau V, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002; 347: 89–94
- Cheson B D, Horning S J, Coiffier B, Shipp M A, Fisher R I, Connors J M, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol 1999; 17: 1244
- Fried M W, Shiffman M L, Reddy K R, Smith C, Marinos G, Goncales F L, Jr, et al. Peginterferon α-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975–982
- Witherspoon R P, Fisher L D, Schoch G, Martin P, Sullivan K M, Sanders J, et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 1989; 321: 784–789
- Curtis R E, Travis L B, Rowlings P A, Sociè G, Kingma D W, Banks P M, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 1999; 94: 2208–2216
- Deeg H J, Sociè G. Malignancies after hematopoietic stem cell transplantation: many questions, some answers. Blood 1998; 91: 1833–1844
- Vallisa D, Bernuzzi P, Arcaini L, Sacchi S, Callea V, Marasca R, et al. Role of anti-hepatitis C virus(HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience. J Clin Oncol 2005; 23: 468–473